Fentanyl and fentanyl-analog involvement in drug-related deaths.

BACKGROUND To describe and analyze the involvement of fentanyl and fentanyl analogs (FAs) in drug-related deaths in West Virginia (WV), United States. METHODS Retrospective analyses of all WV drug-related deaths from 2005 to 2017 were performed, including comparisons of demographic and toxicological characteristics among total deaths, deaths in which fentanyl/FAs were present, deaths in which they were absent, heroin-related deaths, and prescription opioid-related deaths. RESULTS Most of the 8813 drug-related deaths were overdoses, with about 11% resulting from transportation/other injuries in which drugs were contributors. Prescription opioid presence (without fentanyl) decreased by 75% from 2005-14 to 2015-17 (3545 deaths to 859 deaths, respectively), while fentanyl involvement in the deaths increased by 122% between these periods (487 to 1082 deaths). Ten FAs were identified (427 instances) after 2015. Alprazolam and ethanol were among the top five most frequently identified substances across years. Fentanyl, heroin and cocaine replaced oxycodone, diazepam and hydrocodone in the top five beginning in 2015. Few decedents had a prescription for fentanyl after 2015, with fewer prescriptions also present for other controlled substances identified. CONCLUSIONS Fentanyl, rapidly emerging FAs, and other illicit drugs in recent years pose a serious health threat even though prescription opioid-related deaths decreased over the same time period.

[1]  Tara Gomes,et al.  The Burden of Opioid-Related Mortality in the United States , 2018, JAMA network open.

[2]  S. Mars,et al.  Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD , 2018, Journal of psychoactive drugs.

[3]  R. Raffa,et al.  Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin , 2018, Postgraduate medicine.

[4]  Ehsan Jozaghi,et al.  Missing the trends in the fentanyl overdose crisis: The need for immediate intervention in small and rural communities , 2017, Canadian Journal of Public Health.

[5]  Haomiao Jia,et al.  Discerning suicide in drug intoxication deaths: Paucity and primacy of suicide notes and psychiatric history , 2018, PloS one.

[6]  Yunfeng Shi,et al.  State prescription drug monitoring programs and fatal drug overdoses. , 2017, The American journal of managed care.

[7]  E. Wood,et al.  Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis. , 2018, Drug and alcohol dependence.

[8]  J. Costich,et al.  Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance. , 2017, The International journal on drug policy.

[9]  J. Rich,et al.  Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA. , 2017, The International journal on drug policy.

[10]  P. Seth,et al.  Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015 , 2017, Morbidity and Mortality Weekly Report.

[11]  Holly Hedegaard,et al.  Drug Overdose Deaths in the United States, 1999-2016. , 2017, NCHS data brief.

[12]  D. Fowler,et al.  Epidemic Fentanyl Deaths in Maryland: A Public Health Intervention Involving Geographic Information Systems and Collaboration with the Drug Enforcement Administration , 2016, Academic forensic pathology.

[13]  E. Wood,et al.  Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. , 2018, Drug and alcohol dependence.

[14]  J. Hibbs,et al.  An outbreak of designer drug--related deaths in Pennsylvania. , 1991, JAMA.

[15]  Nabarun Dasgupta,et al.  Opioid Crisis: No Easy Fix to Its Social and Economic Determinants. , 2018, American journal of public health.

[16]  Daniel Ciccarone,et al.  US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. , 2017, The International journal on drug policy.

[17]  Joji Suzuki,et al.  A review: Fentanyl and non-pharmaceutical fentanyls. , 2017, Drug and alcohol dependence.

[18]  W. Compton,et al.  Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement , 2018, Annals of Internal Medicine.

[19]  R. Harruff,et al.  Tracking the Opioid Drug Overdose Epidemic in King County, Washington Using an Improved Methodology for Certifying Heroin Related Deaths , 2015 .

[20]  L. Marinetti,et al.  A series of forensic toxicology and drug seizure cases involving illicit fentanyl alone and in combination with heroin, cocaine or heroin and cocaine. , 2014, Journal of analytical toxicology.

[21]  J. Samet,et al.  Suggested Paths to Fixing the Opioid Crisis: Directions and Misdirections. , 2018, JAMA network open.

[22]  M. Karamouzian,et al.  The lessons learned from the fentanyl overdose crises in British Columbia, Canada. , 2017, Addiction.

[23]  Grant T Baldwin,et al.  Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids , 2017, American journal of public health.

[24]  Chris Delcher,et al.  Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses , 2018, Annals of Internal Medicine.

[25]  K. Hempstead,et al.  Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey. , 2014, Health economics.

[26]  Rose A Rudd,et al.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015. , 2016, MMWR. Morbidity and mortality weekly report.

[27]  R. Gerona,et al.  Fentanyl and a Novel Synthetic Opioid U-47700 Masquerading as Street "Norco" in Central California: A Case Report. , 2017, Annals of emergency medicine.

[28]  J. Buxton,et al.  Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada , 2015, Harm Reduction Journal.

[29]  M. Merlin,et al.  Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic , 2017, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[30]  D. Vlahov,et al.  Risk factors for severe respiratory depression from prescription opioid overdose , 2018, Addiction.

[31]  P. Seth,et al.  Quantifying the Epidemic of Prescription Opioid Overdose Deaths , 2018, American journal of public health.

[32]  L. Webster.  Risk Factors for Opioid-Use Disorder and Overdose. , 2017, Anesthesia and analgesia.

[33]  Xander M R van Wijk,et al.  Adverse Effects From Counterfeit Alprazolam Tablets. , 2016, JAMA internal medicine.

[34]  H. Pollack,et al.  Addressing the Fentanyl Threat to Public Health. , 2017, The New England journal of medicine.